相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy
Elena Abati et al.
MOLECULAR NEUROBIOLOGY (2019)
R-Loops in Motor Neuron Diseases
Martina G. L. Perego et al.
MOLECULAR NEUROBIOLOGY (2019)
Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-Tooth phenotype with early onset symptoms
Thomas A. Cassini et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Diagnostic Odyssey and Application of Targeted Exome Sequencing in the Investigation of Recurrent Infant Deaths in a Syrian Consanguineous Family: a Case of Spinal Muscular Atrophy with Respiratory Distress Type 1
Young A. Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2019)
Selective vulnerability in neuronal populations in nmd/SMARD1 mice
Eric Villalon et al.
HUMAN MOLECULAR GENETICS (2018)
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
Ewa Kruminis-Kaszkiel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
Maciej Dabrowski et al.
MOLECULAR MEDICINE (2018)
Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1)
Verena Surrey et al.
NEUROSCIENCE (2018)
The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy
Mathula Thangarajh et al.
NEUROLOGY (2018)
A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1
Monir Shababi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
R Loops and Links to Human Disease
Patricia Richard et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage
Mohini Jangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs
Lixia Wang et al.
PROTEIN & CELL (2017)
The suppression of premature termination codons and the repair of splicing mutations in CFTR
Yifat S. Oren et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination
Dorothy Yanling Zhao et al.
NATURE (2016)
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
Ilary Allodi et al.
SCIENTIFIC REPORTS (2016)
Patient with spinal muscular atrophy with respiratory distress type 1 presenting initially with hypertonia
Chunxi Han et al.
BRAIN & DEVELOPMENT (2015)
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency
Lorenz Studer et al.
CELL STEM CELL (2015)
Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1
Fiammetta Vanoli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair
Elodie Hatchi et al.
MOLECULAR CELL (2015)
R loops: new modulators of genome dynamics and function
Jose M. Santos-Pereira et al.
NATURE REVIEWS GENETICS (2015)
Spinal muscular atrophy-recent therapeutic advances for an old challenge
Irene Faravelli et al.
NATURE REVIEWS NEUROLOGY (2015)
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
Monica Nizzardo et al.
SCIENCE ADVANCES (2015)
CLP1 as a novel player in linking tRNA splicing to neurodegenerative disorders
Stefan Weitzer et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2015)
Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2
Ellen Cottenie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Gene Therapy for Inherited Muscle Diseases Where Genetics Meets Rehabilitation Medicine
Robynne Braun et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2014)
Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1
Frank Krieger et al.
BRAIN (2014)
Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function
Ender Karaca et al.
CELL (2014)
CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration
Ashleigh E. Schaffer et al.
CELL (2014)
Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells
Maria Jedrzejowska et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2014)
One Novel and One Recurrent Mutation in IGHMBP2 Gene, Causing Severe Spinal Muscular Atrophy Respiratory Distress 1 With Onset Soon After Birth
Ivan Litvinenko et al.
JOURNAL OF CHILD NEUROLOGY (2014)
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: A systematic review
Francesca Porro et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Aaron R. Haeusler et al.
NATURE (2014)
Early infantile sensory-motor neuropathy with late onset respiratory distress
Astrid Blaschek et al.
NEUROMUSCULAR DISORDERS (2014)
SMN control of RNP assembly: From post-transcriptional gene regulation to motor neuron disease
Darrick K. Li et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
Chiara Simone et al.
STEM CELL REPORTS (2014)
Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury
Karen J. B. Martins et al.
GROWTH HORMONE & IGF RESEARCH (2013)
Catastrophic Autonomic Crisis With Cardiovascular Collapse in Spinal Muscular Atrophy With Respiratory Distress Type 1
Toshihiro Nomura et al.
JOURNAL OF CHILD NEUROLOGY (2013)
CLP1 links tRNA metabolism to progressive motor-neuron loss
Toshikatsu Hanada et al.
NATURE (2013)
Clinical and mutational characteristics of spinal muscular atrophy with respiratory distress type 1 in the Netherlands
Xenia L. Stalpers et al.
NEUROMUSCULAR DISORDERS (2013)
Infantile spinal muscular atrophy with respiratory distress type I (SMARD 1): An atypical phenotype and review of the literature
Maria F. Messina et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2012)
Structural Basis for 5′-End-Specific Recognition of Single-Stranded DNA by the R3H Domain from Human Sμbp-2
Kristaps Jaudzems et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1
Siew Choo Lim et al.
NUCLEIC ACIDS RESEARCH (2012)
The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)
Maria Eckart et al.
PEDIATRICS (2012)
Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy
Stefania Corti et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation
Devaki Bhaya et al.
ANNUAL REVIEW OF GENETICS, VOL 45 (2011)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination
Konstantina Skourti-Stathaki et al.
MOLECULAR CELL (2011)
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
Amanda M. Haidet-Phillips et al.
NATURE BIOTECHNOLOGY (2011)
Stem Cell Model of Spinal Muscular Atrophy
Allison D. Ebert et al.
ARCHIVES OF NEUROLOGY (2010)
Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1: A Case Report
Abdulaziz AlSaman et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
A New Nonsense Mutation of the IGHMBP2 Gene Responsible for the First Case of SMARD1 in a Sardinian Patient with Giant Cell Hepatitis
V. Fanos et al.
NEUROPEDIATRICS (2010)
Over the barrier and through the blood To CNS delivery we go
Kevin D. Foust et al.
CELL CYCLE (2009)
IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)
Ulf-Peter Guenther et al.
HUMAN MOLECULAR GENETICS (2009)
Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery
Mariangels de Planell-Saguer et al.
HUMAN MOLECULAR GENETICS (2009)
Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease
Ulf-Peter Guenther et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Motoneuron Transplantation Rescues the Phenotype of SMARD1 (Spinal Muscular Atrophy with Respiratory Distress Type 1)
Stefania Corti et al.
JOURNAL OF NEUROSCIENCE (2009)
A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability
Renee D. Paulsen et al.
MOLECULAR CELL (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Interfamilial phenotypic heterogeneity in SMARD1
S. Joseph et al.
NEUROMUSCULAR DISORDERS (2009)
Distal spinal-muscular atrophy 1 (DSMA1 or SMARD1)
A. M. Kaindl et al.
ARCHIVES DE PEDIATRIE (2008)
Self-complementary AAV vectors; Advances and applications
Douglas M. McCarty
MOLECULAR THERAPY (2008)
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
John T. Dimos et al.
SCIENCE (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy
Sibylle Jablonka et al.
JOURNAL OF CELL BIOLOGY (2007)
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Makiko Nagai et al.
NATURE NEUROSCIENCE (2007)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1
Alberto Giannini et al.
INTENSIVE CARE MEDICINE (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease
Ying-Zhang Chen et al.
NEUROBIOLOGY OF DISEASE (2006)
Mutation of gene in spinal muscular atrophy respiratory distress type I
Virginia C. N. Wong et al.
PEDIATRIC NEUROLOGY (2006)
Autonomic dysfunction in cases of spinal muscular atrophy type 1 with long survival
Y Hachiya et al.
BRAIN & DEVELOPMENT (2005)
Dilated cardiomyopathy in the nmd mouse:: transgenic rescue and QTLs that improve cardiac function and survival
TP Maddatu et al.
HUMAN MOLECULAR GENETICS (2005)
Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice
R Ruiz et al.
HUMAN MOLECULAR GENETICS (2005)
Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)
K Grohmann et al.
HUMAN MOLECULAR GENETICS (2004)
Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1
UP Guenther et al.
HUMAN GENETICS (2004)
Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)
S Rudnik-Schöneborn et al.
NEUROPEDIATRICS (2004)
Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy
TP Maddatu et al.
HUMAN MOLECULAR GENETICS (2004)
Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)
K Grohmann et al.
ANNALS OF NEUROLOGY (2003)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1
M Pitt et al.
BRAIN (2003)
Adult stem cell plasticity: Fact or artifact?
M Raff
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2003)
Recruitment of RNA polymerase III to its target promoters
L Schramm et al.
GENES & DEVELOPMENT (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
C Rommel et al.
NATURE CELL BIOLOGY (2001)
Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1
K Grohmann et al.
NATURE GENETICS (2001)
The RNA polymerase III transcription apparatus
EP Geiduschek et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay
A Bhattacharya et al.
RNA (2000)
A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth
T Oda et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Lentiviral vectors: turning a deadly foe into a therapeutic agent
D Trono
GENE THERAPY (2000)
分享论文
